When Aardvark Therapeutics announced earlier this month that it was pausing a phase 3 trial of its lead metabolic candidate, ...

This year on 4 th March, the global health community will unite to raise awareness about the fact that there are numerous root causes for obesity. In particular this year, the Foundation wishes to ...

This little-known biotech company has a different strategy than the established weight-loss drug market leaders. But is it ...

Research from Italy to be presented at this year's European Congress on Obesity (ECO 2026, Istanbul, Türkiye, 12–15 May) and ...

Monthly subs available through telehealth services will help Novo solidify its orals lead in advance of Lilly’s expected entry into the category.

Shares of Viking Therapeutics VKTX rose more than 3% on Thursday after the company announced that it completed enrollment in ...

Wave Life Sciences shares plunged >50% after Phase 1 INLIGHT data for WVE-007 showed <1% placebo-adjusted weight loss at six ...

From hidden body fat in “skinny fat” individuals to the risks of dirty bulking and myths about being “big-boned”, doctors ...

In the battle of the obesity bulge, glucagon-like peptide-1 receptor agonist medications — aka GLP-1s such as Wegovy and Zepbound — have changed the game for some people who've struggled to ...

Trump continues to be mad that he can't pardon a state conviction, so he's punishing everyone in Colorado over felon Tina ...